explore -WSS

explore

author：hotspot 2025-09-29 21:23:29 - browse：76

Novo Nordisk headquarters -- health coverage from STAT — Novo Nordisk's headquarters, outside Copenhagen, Denmark. LISELOTTE SABROE/Scanpix/AFP via Getty Images

Novo Nordisk is pausing ads for its obesity drug Wegovy as it struggles to keep up with surging demand, the latest hurdle in its rollout of the weight loss drug.

“To avoid stimulating further demand for this medicine, we’re pausing some key Wegovy promotional efforts,” the Danish drugmaker said in an emailed statement. “We are pausing all local television advertising and postponing planned national television advertising for Wegovy. We are also assessing our promotional efforts to healthcare professionals and adjusting accordingly.” The news was earlier reported by Endpoints.

Wegovy, which contains the active ingredient semaglutide, has become immensely popular for its effectiveness in helping people lose weight and is helping usher in what many see as a sea change in obesity treatment. Its sister drug for diabetes, Ozempic, has also been in demand for a similar effect on weight loss.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Blinken talks high

WSS

Tommy Tuberville reverses his claim that white nationalists are unfairly labeled racist

Russia's threat to pull out of Ukraine grain deal raises fears about global food security

Many immigrants are left out of maternal health programs

Superbugs, antibiotic resistance get scrutiny in congress

Young Chinese opt out of the rat race and pressures at home to pursue global nomad lifestyle

Judge orders hearing on Trump's motion to disqualify Fulton County DA

leisure time

explore

Wikipedia

As demand for Covid shots wanes, Moderna seeks its next success

Sickle cell gene therapy cures need to be accessible in Africa

Trump demands the U.S. pay no more for drugs than other countries … again

After half a century, Israel moves to evict squatter from his cave home on the beach

In age of alternative facts, a scholarly course on calling out crap

Sudan conflict brings new atrocities to Darfur as militias kill, rape, burn homes in rampages

United colonoscopy coverage change 'may cost lives,' doctors say

How are insurers handling Leqembi and related scans?

Medical leaders decry Supreme Court decision on affirmative action

How are insurers handling Leqembi and related scans?

Wikipedia

Digital health funding stays low as a new reality sets in

Antibody drugs appear effective. Now can we make enough of them?

Women's World Cup brings attention to abuse in soccer

Tommy Tuberville reverses his claim that white nationalists are unfairly labeled racist

Tommy Tuberville reverses his claim that white nationalists are unfairly labeled racist

China sends large group of warplanes, navy ships towards Taiwan in forceful display

focus

hotspot

hotspot

explore